| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | NAD transmembrane transporter activity | 1.46e-05 | 5 | 229 | 3 | GO:0051724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 ATP8B4 MYO1A ACSM1 KIF4A CHD2 AK9 DDX6 KIF14 DDX60L ABCC1 DDX12P DDX60 WRN ABCE1 DNAH17 MACF1 XRCC6 HELLS | 9.10e-05 | 614 | 229 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | alpha-1A adrenergic receptor binding | 1.31e-04 | 2 | 229 | 2 | GO:0031691 | |
| GeneOntologyMolecularFunction | angiotensin receptor binding | 1.68e-04 | 10 | 229 | 3 | GO:0031701 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 2.07e-04 | 26 | 229 | 4 | GO:0000295 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 3.19e-04 | 29 | 229 | 4 | GO:0015216 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 3.90e-04 | 3 | 229 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | follicle-stimulating hormone receptor binding | 3.90e-04 | 3 | 229 | 2 | GO:0031762 | |
| GeneOntologyMolecularFunction | alpha-1B adrenergic receptor binding | 3.90e-04 | 3 | 229 | 2 | GO:0031692 | |
| GeneOntologyMolecularFunction | helicase activity | 4.88e-04 | 158 | 229 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | gated channel activity | PIEZO1 BEST3 ITPR2 ITPR3 PTK2B CLCN2 CLCN7 SCN7A SCNN1B TRPM8 PIEZO2 P2RX5 | 5.02e-04 | 334 | 229 | 12 | GO:0022836 |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 5.31e-04 | 33 | 229 | 4 | GO:0015215 | |
| GeneOntologyMolecularFunction | kinase activity | CDK17 CDKL3 AK9 PXK MAP3K5 NRP1 PHKA1 PTK2B MYLK4 FAM20B PIP5K1A ROCK2 MINK1 PDPK2P STK16 LIMK1 EPHA2 PRKCD EIF2AK4 EIF2AK2 | 5.35e-04 | 764 | 229 | 20 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CDK17 CDKL3 PXK MAP3K5 NRP1 PHKA1 PTK2B MYLK4 FAM20B PIP5K1A ROCK2 MINK1 PDPK2P STK16 LIMK1 EPHA2 PRKCD EIF2AK4 EIF2AK2 | 5.56e-04 | 709 | 229 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | protein kinase activity | CDK17 CDKL3 PXK MAP3K5 NRP1 PHKA1 PTK2B MYLK4 ROCK2 MINK1 PDPK2P STK16 LIMK1 EPHA2 PRKCD EIF2AK4 EIF2AK2 | 5.87e-04 | 600 | 229 | 17 | GO:0004672 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA1 ATP8B4 CHD2 AK9 DDX6 KIF14 DDX60L ABCC1 DDX12P DDX60 WRN ABCE1 MACF1 XRCC6 | 6.01e-04 | 441 | 229 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDK17 CDKL3 MAP3K5 PHKA1 PTK2B MYLK4 ROCK2 MINK1 PDPK2P STK16 LIMK1 PRKCD EIF2AK4 EIF2AK2 | 6.71e-04 | 446 | 229 | 14 | GO:0004674 |
| GeneOntologyMolecularFunction | hedgehog family protein binding | 7.74e-04 | 4 | 229 | 2 | GO:0097108 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 1.01e-03 | 39 | 229 | 4 | GO:0015605 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 1.04e-03 | 137 | 229 | 7 | GO:0019783 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 1.28e-03 | 5 | 229 | 2 | GO:0015207 | |
| GeneOntologyBiologicalProcess | NAD transmembrane transport | 1.23e-05 | 5 | 223 | 3 | GO:0035352 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | RIPOR2 CDKL3 DCC PTCH1 ADAM8 ITGB3 NRP1 PTK2B GRXCR2 DST STXBP1 NBEAL2 SEC24B ROCK2 MINK1 L1CAM NR4A3 XK SRGAP2 CFAP43 JMJD1C BTBD3 POSTN LIF LIMK1 EPHA2 MACF1 EIF2AK4 TRAK2 MYO16 | 1.46e-05 | 1194 | 223 | 30 | GO:0000902 |
| GeneOntologyBiologicalProcess | nucleotide transport | 1.59e-05 | 50 | 223 | 6 | GO:0006862 | |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 2.29e-05 | 108 | 223 | 8 | GO:0007044 | |
| GeneOntologyBiologicalProcess | NAD transport | 2.43e-05 | 6 | 223 | 3 | GO:0043132 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 3.61e-05 | 115 | 223 | 8 | GO:0150115 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | NUGGC PRAMEF2 ADAM8 ADAR BIRC6 ITGB3 NRP1 GHRH PTK2B SERPINB9 STXBP1 ALMS1 SCG2 MITF KIF14 NOS1 SLC25A4 NR4A3 UFL1 PDPK2P EDNRB HHIP ARRB1 ARRB2 PRKCD CCAR2 EIF2AK2 HELLS | 3.89e-05 | 1133 | 223 | 28 | GO:0043066 |
| GeneOntologyBiologicalProcess | chemotaxis | RIPOR2 ADAM8 ITGB3 NRP1 PTK2B SCG2 PIP5K1A CCR4 DOCK2 ABCC1 L1CAM CCRL2 EDNRB USP14 ARRB2 EPHA2 PRKCD | 5.07e-05 | 517 | 223 | 17 | GO:0006935 |
| GeneOntologyBiologicalProcess | taxis | RIPOR2 ADAM8 ITGB3 NRP1 PTK2B SCG2 PIP5K1A CCR4 DOCK2 ABCC1 L1CAM CCRL2 EDNRB USP14 ARRB2 EPHA2 PRKCD | 5.32e-05 | 519 | 223 | 17 | GO:0042330 |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | RIPOR2 PIEZO1 PTCH1 RRM1 ADAM8 ITGB3 HP1BP3 ITPR2 PTK2B KARS1 CLCN7 SCN7A SCNN1B TRPM8 NOS1 ROCK2 WRN COPS3 PDPK2P POSTN LIF EYS PIEZO2 ARRB1 ARRB2 P2RX5 RRH PRKCD CCAR2 EIF2AK4 XRCC6 | 6.76e-05 | 1361 | 223 | 31 | GO:0009628 |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 6.83e-05 | 40 | 223 | 5 | GO:0072530 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | NUGGC PRAMEF2 ADAM8 ADAR BIRC6 ITGB3 NRP1 GHRH PTK2B SERPINB9 STXBP1 ALMS1 SCG2 MITF KIF14 NOS1 SLC25A4 NR4A3 UFL1 PDPK2P EDNRB HHIP ARRB1 ARRB2 PRKCD CCAR2 EIF2AK2 HELLS | 6.90e-05 | 1171 | 223 | 28 | GO:0043069 |
| GeneOntologyBiologicalProcess | organophosphate ester transport | ABCA1 ATP8B4 SLC25A17 ABCC1 SLC25A4 SLC25A51 EPG5 PRKCD SLC25A52 | 6.94e-05 | 162 | 223 | 9 | GO:0015748 |
| GeneOntologyBiologicalProcess | maintenance of protein complex location | 1.16e-04 | 2 | 223 | 2 | GO:0098544 | |
| GeneOntologyBiologicalProcess | positive regulation of opioid receptor signaling pathway | 1.16e-04 | 2 | 223 | 2 | GO:2000476 | |
| GeneOntologyBiologicalProcess | mitochondrial NAD transmembrane transport | 1.16e-04 | 2 | 223 | 2 | GO:1990549 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | RIPOR2 MYO1A FRMD7 ODAD4 RABGAP1 BBS9 NRP1 ALMS1 PIP5K1A CFAP47 CNTRL MINK1 SRGAP2 CFAP43 EPHA2 DNAH17 PRKCD CFAP74 CFAP69 | 1.31e-04 | 670 | 223 | 19 | GO:0120031 |
| GeneOntologyBiologicalProcess | regulation of muscle cell apoptotic process | 1.52e-04 | 141 | 223 | 8 | GO:0010660 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | ITPR2 ITPR3 ALMS1 TRPM8 CCR4 NOS1 ANK2 L1CAM CCRL2 EDNRB P2RX5 | 1.59e-04 | 266 | 223 | 11 | GO:0019722 |
| GeneOntologyBiologicalProcess | cell chemotaxis | RIPOR2 ADAM8 NRP1 PTK2B SCG2 PIP5K1A CCR4 ABCC1 CCRL2 EDNRB ARRB2 EPHA2 PRKCD | 1.72e-04 | 363 | 223 | 13 | GO:0060326 |
| GeneOntologyBiologicalProcess | cell projection assembly | RIPOR2 MYO1A FRMD7 ODAD4 RABGAP1 BBS9 NRP1 ALMS1 PIP5K1A CFAP47 CNTRL MINK1 SRGAP2 CFAP43 EPHA2 DNAH17 PRKCD CFAP74 CFAP69 | 1.74e-04 | 685 | 223 | 19 | GO:0030031 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | ADAM8 ITGB3 NRP1 PTK2B PIP5K1A ROCK2 MINK1 L1CAM PDPK2P POSTN MACF1 | 1.81e-04 | 270 | 223 | 11 | GO:0007160 |
| GeneOntologyBiologicalProcess | axoneme assembly | 1.84e-04 | 109 | 223 | 7 | GO:0035082 | |
| GeneOntologyBiologicalProcess | muscle cell apoptotic process | 2.32e-04 | 150 | 223 | 8 | GO:0010657 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron apoptotic process | 2.60e-04 | 236 | 223 | 10 | GO:0043524 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ABCA1 PDE9A PTCH1 DDX6 ITPR3 PTK2B DST STXBP1 SYNJ1 RAB40AL NOS1 ANK2 CNTRL PPP1R13B COPS3 RAB40A EPG5 STK16 LIMK1 UNC45B LNPEP PRKCD EIF2AK2 MYO16 | 8.57e-05 | 934 | 227 | 24 | GO:0048471 |
| GeneOntologyCellularComponent | alpha9-beta1 integrin-ADAM8 complex | 1.17e-04 | 2 | 227 | 2 | GO:0071133 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.24e-04 | 45 | 227 | 5 | GO:0044295 | |
| GeneOntologyCellularComponent | A band | 2.48e-04 | 52 | 227 | 5 | GO:0031672 | |
| GeneOntologyCellularComponent | motile cilium | CFAP251 ODAD4 PRAMEF2 DDX6 HAVCR1 CFAP47 CFAP43 TMEM232 DNAH17 CFAP74 CATSPERB CFAP69 | 5.33e-04 | 355 | 227 | 12 | GO:0031514 |
| GeneOntologyCellularComponent | cytoplasmic region | CFAP251 KIF4A ODAD4 DST STXBP1 BSN CNTRL CFAP43 DNAH17 CFAP74 TRAK2 CFAP69 | 6.03e-04 | 360 | 227 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | retromer, cargo-selective complex | 6.94e-04 | 4 | 227 | 2 | GO:0030906 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | CFAP251 KIF4A ODAD4 DST BSN CNTRL CFAP43 DNAH17 CFAP74 TRAK2 CFAP69 | 7.30e-04 | 317 | 227 | 11 | GO:0032838 |
| GeneOntologyCellularComponent | proteasome complex | 8.07e-04 | 67 | 227 | 5 | GO:0000502 | |
| GeneOntologyCellularComponent | cilium | CFAP251 TTC21A ODAD4 PTCH1 PRAMEF2 BBS9 DDX6 HAVCR1 ALMS1 CFAP47 CNTRL CFAP43 TTLL7 HHIP EYS TMEM232 DNAH17 RRH CFAP74 CATSPERB CFAP69 | 8.23e-04 | 898 | 227 | 21 | GO:0005929 |
| HumanPheno | Coiled sperm flagella | 2.83e-07 | 32 | 75 | 7 | HP:0032560 | |
| HumanPheno | Short sperm flagella | 3.55e-07 | 33 | 75 | 7 | HP:0032559 | |
| HumanPheno | Abnormal sperm tail morphology | 2.38e-06 | 43 | 75 | 7 | HP:0012868 | |
| HumanPheno | Abnormal sperm morphology | 4.39e-05 | 66 | 75 | 7 | HP:0012864 | |
| HumanPheno | Absent sperm flagella | 4.56e-05 | 28 | 75 | 5 | HP:0032558 | |
| HumanPheno | Abnormal germ cell morphology | 4.85e-05 | 67 | 75 | 7 | HP:0012862 | |
| HumanPheno | Abnormal male germ cell morphology | 4.85e-05 | 67 | 75 | 7 | HP:0012863 | |
| Domain | ARM-type_fold | RIPOR2 PSMD1 ARMH1 USP9Y ITPR2 PSME4 NBEAL2 ASPM CAB39L TARBP1 DOCK2 COPB1 USP24 CWC22 VIRMA RANBP17 UNC45B CFAP69 XPO7 | 2.35e-08 | 339 | 221 | 19 | IPR016024 |
| Domain | ARM-like | RIPOR2 PSMD1 ARMH1 USP9Y PSME4 NBEAL2 ASPM CAB39L TARBP1 DOCK2 COPB1 RANBP17 UNC45B CFAP69 XPO7 | 8.26e-07 | 270 | 221 | 15 | IPR011989 |
| Domain | - | SLC25A30 SLC25A17 SLC25A4 SLC25A14 SLC25A51 SLC25A44 SLC25A52 | 2.87e-06 | 53 | 221 | 7 | 1.50.40.10 |
| Domain | Mito_carr | SLC25A30 SLC25A17 SLC25A4 SLC25A14 SLC25A51 SLC25A44 SLC25A52 | 2.87e-06 | 53 | 221 | 7 | PF00153 |
| Domain | SOLCAR | SLC25A30 SLC25A17 SLC25A4 SLC25A14 SLC25A51 SLC25A44 SLC25A52 | 2.87e-06 | 53 | 221 | 7 | PS50920 |
| Domain | Mitochondrial_sb/sol_carrier | SLC25A30 SLC25A17 SLC25A4 SLC25A14 SLC25A51 SLC25A44 SLC25A52 | 2.87e-06 | 53 | 221 | 7 | IPR018108 |
| Domain | Mt_carrier_dom | SLC25A30 SLC25A17 SLC25A4 SLC25A14 SLC25A51 SLC25A44 SLC25A52 | 2.87e-06 | 53 | 221 | 7 | IPR023395 |
| Domain | Mit_uncoupling | 8.77e-06 | 12 | 221 | 4 | IPR002030 | |
| Domain | - | 3.18e-05 | 6 | 221 | 3 | 3.90.1290.10 | |
| Domain | Plectin | 5.52e-05 | 7 | 221 | 3 | PF00681 | |
| Domain | Plectin_repeat | 5.52e-05 | 7 | 221 | 3 | IPR001101 | |
| Domain | PLEC | 5.52e-05 | 7 | 221 | 3 | SM00250 | |
| Domain | PIEZO | 1.39e-04 | 2 | 221 | 2 | PF15917 | |
| Domain | Piezo | 1.39e-04 | 2 | 221 | 2 | IPR027272 | |
| Domain | Piezo_RRas_bdg | 1.39e-04 | 2 | 221 | 2 | PF12166 | |
| Domain | Piezo_RRas-bd_dom | 1.39e-04 | 2 | 221 | 2 | IPR031334 | |
| Domain | Piezo_dom | 1.39e-04 | 2 | 221 | 2 | IPR031805 | |
| Domain | UCH | 1.93e-04 | 71 | 221 | 6 | PF00443 | |
| Domain | USP_3 | 2.09e-04 | 72 | 221 | 6 | PS50235 | |
| Domain | USP_dom | 2.09e-04 | 72 | 221 | 6 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 2.09e-04 | 72 | 221 | 6 | IPR001394 | |
| Domain | Aden_trnslctor | 3.13e-04 | 28 | 221 | 4 | IPR002113 | |
| Domain | - | RIPOR2 PSMD1 ARMH1 PSME4 ASPM CAB39L COPB1 RANBP17 UNC45B CFAP69 | 3.24e-04 | 222 | 221 | 10 | 1.25.10.10 |
| Domain | Vps26-related | 4.15e-04 | 3 | 221 | 2 | IPR028934 | |
| Domain | MITF_TFEB_C_3_N | 4.15e-04 | 3 | 221 | 2 | PF15951 | |
| Domain | Vps26 | 4.15e-04 | 3 | 221 | 2 | PF03643 | |
| Domain | InsP3_rcpt-bd | 4.15e-04 | 3 | 221 | 2 | IPR000493 | |
| Domain | Elf-1_N | 4.15e-04 | 3 | 221 | 2 | PF12310 | |
| Domain | MiT/TFE_N | 4.15e-04 | 3 | 221 | 2 | IPR031867 | |
| Domain | TF_Elf_N | 4.15e-04 | 3 | 221 | 2 | IPR022084 | |
| Domain | TPR-like_helical_dom | TTC21A ODAD4 PSMD6 COPS3 ZFC3H1 RMDN3 UNC45B CAPN7 COPS4 NUB1 | 4.74e-04 | 233 | 221 | 10 | IPR011990 |
| Domain | Mit_carrier | 5.29e-04 | 32 | 221 | 4 | IPR002067 | |
| Domain | IQ_motif_EF-hand-BS | 6.98e-04 | 90 | 221 | 6 | IPR000048 | |
| Domain | Kinase-like_dom | CDK17 CDKL3 PXK MAP3K5 PTK2B DST MYLK4 ROCK2 MINK1 STK16 LIMK1 EPHA2 MACF1 PRKCD EIF2AK4 EIF2AK2 | 7.58e-04 | 542 | 221 | 16 | IPR011009 |
| Domain | Disintegrin_CS | 8.17e-04 | 16 | 221 | 3 | IPR018358 | |
| Domain | PINT | 8.17e-04 | 16 | 221 | 3 | SM00088 | |
| Domain | Arrestin_N | 8.23e-04 | 4 | 221 | 2 | IPR014753 | |
| Domain | Arrestin_CS | 8.23e-04 | 4 | 221 | 2 | IPR017864 | |
| Domain | ARRESTINS | 8.23e-04 | 4 | 221 | 2 | PS00295 | |
| Domain | DUF3371 | 8.23e-04 | 4 | 221 | 2 | PF11851 | |
| Domain | Arrestin | 8.23e-04 | 4 | 221 | 2 | IPR000698 | |
| Domain | - | 8.23e-04 | 4 | 221 | 2 | 2.60.40.840 | |
| Domain | MiT/TFE_C | 8.23e-04 | 4 | 221 | 2 | IPR021802 | |
| Domain | PCI_dom | 9.83e-04 | 17 | 221 | 3 | IPR000717 | |
| Domain | PCI | 9.83e-04 | 17 | 221 | 3 | PF01399 | |
| Domain | USP_CS | 1.10e-03 | 66 | 221 | 5 | IPR018200 | |
| Domain | ADAM_CR | 1.17e-03 | 18 | 221 | 3 | PF08516 | |
| Domain | USP_1 | 1.44e-03 | 70 | 221 | 5 | PS00972 | |
| Domain | USP_2 | 1.53e-03 | 71 | 221 | 5 | PS00973 | |
| Domain | Ubiquitin-rel_dom | 1.60e-03 | 184 | 221 | 8 | IPR029071 | |
| Domain | - | 1.61e-03 | 20 | 221 | 3 | 4.10.70.10 | |
| Domain | Helicase_C | 1.72e-03 | 107 | 221 | 6 | PF00271 | |
| Domain | HELICc | 1.72e-03 | 107 | 221 | 6 | SM00490 | |
| Domain | Helicase_C | 1.80e-03 | 108 | 221 | 6 | IPR001650 | |
| Domain | Disintegrin | 1.86e-03 | 21 | 221 | 3 | PF00200 | |
| Domain | DISIN | 1.86e-03 | 21 | 221 | 3 | SM00050 | |
| Domain | HELICASE_CTER | 1.89e-03 | 109 | 221 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.89e-03 | 109 | 221 | 6 | PS51192 | |
| Domain | DEXDc | 1.89e-03 | 109 | 221 | 6 | SM00487 | |
| Domain | Protein_kinase_ATP_BS | CDK17 CDKL3 MAP3K5 PTK2B MYLK4 ROCK2 MINK1 LIMK1 EPHA2 PRKCD EIF2AK4 EIF2AK2 | 1.93e-03 | 379 | 221 | 12 | IPR017441 |
| Domain | Helicase_ATP-bd | 1.98e-03 | 110 | 221 | 6 | IPR014001 | |
| Domain | Pkinase | CDK17 CDKL3 PXK MAP3K5 MYLK4 ROCK2 MINK1 STK16 LIMK1 PRKCD EIF2AK4 EIF2AK2 | 2.01e-03 | 381 | 221 | 12 | PF00069 |
| Domain | Sec23/24_helical_dom | 2.03e-03 | 6 | 221 | 2 | IPR006900 | |
| Domain | RIH_assoc-dom | 2.03e-03 | 6 | 221 | 2 | IPR013662 | |
| Domain | Sec23_24_beta_S | 2.03e-03 | 6 | 221 | 2 | IPR012990 | |
| Domain | zf-Sec23_Sec24 | 2.03e-03 | 6 | 221 | 2 | PF04810 | |
| Domain | Sec23_trunk | 2.03e-03 | 6 | 221 | 2 | PF04811 | |
| Domain | Sec23_helical | 2.03e-03 | 6 | 221 | 2 | PF04815 | |
| Domain | GAR | 2.03e-03 | 6 | 221 | 2 | PS51460 | |
| Domain | Ins145_P3_rec | 2.03e-03 | 6 | 221 | 2 | PF08709 | |
| Domain | GAS2 | 2.03e-03 | 6 | 221 | 2 | PF02187 | |
| Domain | RIH_assoc | 2.03e-03 | 6 | 221 | 2 | PF08454 | |
| Domain | RIH_dom | 2.03e-03 | 6 | 221 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.03e-03 | 6 | 221 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.03e-03 | 6 | 221 | 2 | IPR015925 | |
| Domain | Sec23_BS | 2.03e-03 | 6 | 221 | 2 | PF08033 | |
| Domain | - | 2.03e-03 | 6 | 221 | 2 | 1.25.10.30 | |
| Domain | - | 2.03e-03 | 6 | 221 | 2 | 3.30.920.20 | |
| Domain | RYDR_ITPR | 2.03e-03 | 6 | 221 | 2 | PF01365 | |
| Domain | Sec23/24_trunk_dom | 2.03e-03 | 6 | 221 | 2 | IPR006896 | |
| Domain | Znf_Sec23_Sec24 | 2.03e-03 | 6 | 221 | 2 | IPR006895 | |
| Domain | GAS_dom | 2.03e-03 | 6 | 221 | 2 | IPR003108 | |
| Domain | GAS2 | 2.03e-03 | 6 | 221 | 2 | SM00243 | |
| Domain | FERM_M | 2.11e-03 | 46 | 221 | 4 | PF00373 | |
| Domain | Prot_kinase_dom | CDK17 CDKL3 PXK MAP3K5 PTK2B MYLK4 ROCK2 MINK1 STK16 LIMK1 EPHA2 PRKCD EIF2AK4 EIF2AK2 | 2.13e-03 | 489 | 221 | 14 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | CDK17 CDKL3 PXK MAP3K5 PTK2B MYLK4 ROCK2 MINK1 STK16 LIMK1 EPHA2 PRKCD EIF2AK4 EIF2AK2 | 2.30e-03 | 493 | 221 | 14 | PS50011 |
| Domain | - | 2.66e-03 | 49 | 221 | 4 | 1.20.80.10 | |
| Domain | FERM_central | 2.66e-03 | 49 | 221 | 4 | IPR019748 | |
| Domain | FERM_domain | 2.66e-03 | 49 | 221 | 4 | IPR000299 | |
| Domain | IQ | 2.74e-03 | 81 | 221 | 5 | SM00015 | |
| Domain | FERM_CS | 2.75e-03 | 24 | 221 | 3 | IPR019747 | |
| Domain | - | 2.81e-03 | 7 | 221 | 2 | 2.60.40.640 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 2.87e-03 | 50 | 221 | 4 | IPR014352 | |
| Domain | FERM_1 | 2.87e-03 | 50 | 221 | 4 | PS00660 | |
| Domain | FERM_2 | 2.87e-03 | 50 | 221 | 4 | PS00661 | |
| Domain | FERM_3 | 2.87e-03 | 50 | 221 | 4 | PS50057 | |
| Domain | Band_41_domain | 2.87e-03 | 50 | 221 | 4 | IPR019749 | |
| Domain | B41 | 2.87e-03 | 50 | 221 | 4 | SM00295 | |
| Domain | fn3 | 3.21e-03 | 162 | 221 | 7 | PF00041 | |
| Domain | PROTEIN_KINASE_ATP | CDK17 CDKL3 MAP3K5 PTK2B MYLK4 ROCK2 MINK1 STK16 LIMK1 EPHA2 PRKCD EIF2AK4 EIF2AK2 | 3.34e-03 | 459 | 221 | 13 | PS00107 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDCD2 RPS10 KIF4A PSMD1 CHD2 RRM1 ADAR BIRC6 DDX6 KARS1 DST PSME4 GLYR1 SEC24B ASPM AP1M1 DDX60L COPB1 DSP COPS3 VPS26A DIS3 USP14 ARRB2 ABCE1 CSTF1 MACF1 PRKCD CCAR2 EIF2AK2 XRCC6 | 2.38e-09 | 1353 | 232 | 31 | 29467282 |
| Pubmed | RPS10 KIF4A PSMD1 CHD2 BIRC6 HP1BP3 ITPR3 KARS1 DST GLYR1 KIF14 COPB1 DSP USP24 VIRMA DIS3 ABCE1 MACF1 CCAR2 XRCC6 XPO7 | 3.69e-09 | 653 | 232 | 21 | 22586326 | |
| Pubmed | RPS10 KIF4A PSMD1 TUBGCP4 ADAR BIRC6 CLCC1 DDX6 ITPR2 ITPR3 SERPINB9 CLCN7 NBEAL2 DHCR24 KIF14 AP1M1 ZDHHC13 SLC25A17 DOCK2 ABCC1 COPB1 CNTRL DIS3 ABCE1 LNPEP EIF2AK2 XRCC6 | 2.33e-08 | 1168 | 232 | 27 | 19946888 | |
| Pubmed | The mitochondrial transporter family SLC25: identification, properties and physiopathology. | SLC25A30 SLC25A17 SLC25A4 SLC25A14 SLC25A51 SLC25A44 SLC25A52 | 6.37e-08 | 53 | 232 | 7 | 23266187 |
| Pubmed | LRRC49 KIF4A PSMD1 PSMD6 KARS1 COPB1 DSP MINK1 UFL1 COPS3 CWC22 EPHA2 COPS4 CCAR2 XRCC6 | 9.25e-08 | 399 | 232 | 15 | 37536630 | |
| Pubmed | TUBGCP4 ITGB3 HP1BP3 NRP1 DST PSME4 PIP5K1A AP1M1 PZP SLC25A17 SLC25A4 MINK1 CWC22 JMJD1C DIS3 ABCE1 EIF2AK4 TNFAIP2 HELLS | 9.37e-08 | 650 | 232 | 19 | 38777146 | |
| Pubmed | CDK17 TTC21A LRRC49 RPS10 DDX6 HP1BP3 ITPR2 PSMD6 PTK2B KARS1 DST STXBP1 SYNJ1 TLN2 BSN NOS1 ROCK2 IQSEC3 ANK2 SLC25A4 COPB1 DSP MINK1 L1CAM SRGAP2 COPS3 VIRMA MACF1 CEP170B | 1.14e-07 | 1431 | 232 | 29 | 37142655 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | CDK17 PCDHB5 RPS10 KIF4A PSMD1 ODAD4 DDX6 PSMD6 PTPN3 ASPM CAB39L ROCK2 DSP UFL1 SRGAP2 COPS3 JMJD1C TFE3 STK16 RMDN3 ARRB1 ARRB2 COPS4 CCAR2 EIF2AK2 HELLS XPO7 | 1.57e-07 | 1284 | 232 | 27 | 17353931 |
| Pubmed | SEC24A PSMD1 BIRC6 CLCC1 ITPR2 ITPR3 PSMD6 PHKA1 PTPN3 KARS1 CLCN7 GLYR1 SEC24B KIF14 ABCC1 DSP CTDSPL2 MINK1 PPP1R13B POSTN LNPEP CCAR2 EIF2AK4 HELLS | 1.79e-07 | 1049 | 232 | 24 | 27880917 | |
| Pubmed | SEC24A PSMD1 RRM1 CLCC1 DDX6 PSMD6 DST SEC24B ROCK2 ANK2 COPB1 DSP MINK1 USP24 JMJD1C ABCE1 EPHA2 MACF1 XRCC6 | 3.46e-07 | 708 | 232 | 19 | 39231216 | |
| Pubmed | PDCD2 PSMD1 RRM1 ADAR DDX6 PSMD6 AP1M1 BSN ROCK2 COPB1 UFL1 DIS3 ABCE1 COPS4 CCAR2 NUB1 XRCC6 HELLS | 4.84e-07 | 653 | 232 | 18 | 33742100 | |
| Pubmed | PSMD1 DST STXBP1 SYNJ1 BSN IQSEC3 ANK2 SLC25A4 MINK1 L1CAM PDPK2P MACF1 CEP170B | 7.04e-07 | 347 | 232 | 13 | 17114649 | |
| Pubmed | ACACB LRRC49 PSMD1 RABGAP1 BIRC6 DST ALMS1 SYNJ1 KIF14 DSP USP24 ZDBF2 JMJD1C ARRB2 | 9.93e-07 | 418 | 232 | 14 | 34709266 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SEC24A RPS10 KIF4A PSMD1 RRM1 BIRC6 DDX6 HP1BP3 KARS1 DHCR24 AP1M1 TARBP1 ROCK2 SLC25A4 DSP USP24 UFL1 SRGAP2 DIS3 ARRB1 DNAJC17 ARRB2 MACF1 CCAR2 EIF2AK2 XRCC6 HELLS | 1.03e-06 | 1415 | 232 | 27 | 28515276 |
| Pubmed | ACACB LRRC49 DST STXBP1 PIP5K1A ROCK2 ABCC1 MINK1 PPP1R13B UFL1 SRGAP2 ARRB2 EPHA2 MACF1 | 1.08e-06 | 421 | 232 | 14 | 36976175 | |
| Pubmed | 1.17e-06 | 4 | 232 | 3 | 25589675 | ||
| Pubmed | 1.17e-06 | 4 | 232 | 3 | 11356842 | ||
| Pubmed | 1.17e-06 | 4 | 232 | 3 | 19306926 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP8B4 RPS10 PSMD1 ADAR DDX6 PSMD6 KARS1 GLYR1 DHCR24 KIF14 AP1M1 TLN2 BSN COPB1 DSP UFL1 COPS3 CWC22 DIS3 ABCE1 COPS4 CSTF1 PRKCD CCAR2 EIF2AK2 XRCC6 HELLS | 1.18e-06 | 1425 | 232 | 27 | 30948266 |
| Pubmed | ACACB SEC24A KIF4A BIRC6 CLCC1 HP1BP3 PTPN3 DST SEC24B COPB1 CNTRL MINK1 WRN MUC16 BTBD3 EPHA2 CCAR2 HELLS XPO7 | 1.38e-06 | 777 | 232 | 19 | 35844135 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ACACB KIF4A ADAR HP1BP3 KARS1 DST ALMS1 SYNJ1 SEC24B ANK2 COPB1 DSP SRGAP2 DIS3 USP14 ABCE1 COPS4 MACF1 ELF2 XRCC6 HELLS | 1.44e-06 | 934 | 232 | 21 | 33916271 |
| Pubmed | RABGAP1 CLCC1 ITPR2 ITPR3 DST CLCN7 SEC24B ZDHHC13 FNIP2 VPS26B VPS26A ATF6B RMDN3 LNPEP EPHA2 | 1.76e-06 | 504 | 232 | 15 | 34432599 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.81e-06 | 212 | 232 | 10 | 33853758 | |
| Pubmed | KIF4A ADAR KRT80 DDX6 HP1BP3 ITPR3 DST KIF14 CTDSPL2 SRGAP2 CWC22 ARRB2 EPHA2 CSTF1 MACF1 EIF2AK2 XRCC6 | 2.53e-06 | 660 | 232 | 17 | 32780723 | |
| Pubmed | ACACB PSMD1 RABGAP1 BIRC6 PSMD6 STXBP1 SYNJ1 GLYR1 AP1M1 TLN2 BSN NOS1 IQSEC3 ANK2 DSP MINK1 USP24 ZDBF2 SLC25A51 ABCE1 MACF1 SLC25A52 CEP170B | 2.72e-06 | 1139 | 232 | 23 | 36417873 | |
| Pubmed | RABGAP1 DDX6 PTK2B KARS1 ALMS1 DHCR24 AP1M1 DSP COPS3 VIRMA ARRB2 COPS4 CCAR2 EIF2AK2 | 2.81e-06 | 457 | 232 | 14 | 22190034 | |
| Pubmed | Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity. | 2.90e-06 | 5 | 232 | 3 | 36323321 | |
| Pubmed | 2.90e-06 | 5 | 232 | 3 | 21209915 | ||
| Pubmed | Viral delivery of L1CAM promotes axonal extensions by embryonic cerebral grafts in mouse brain. | 2.90e-06 | 5 | 232 | 3 | 36963389 | |
| Pubmed | 2.90e-06 | 5 | 232 | 3 | 19782076 | ||
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 2.90e-06 | 5 | 232 | 3 | 21568942 | |
| Pubmed | 2.96e-06 | 224 | 232 | 10 | 32941674 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | SEC24A PSMD1 BIRC6 ITGB3 KARS1 C3 COPB1 VPS26B USP24 VPS26A ARRB2 XPO7 | 3.95e-06 | 344 | 232 | 12 | 30333137 |
| Pubmed | 4.36e-06 | 234 | 232 | 10 | 36243803 | ||
| Pubmed | ACACB MYO1A TRO PSMD1 CHD2 DCC HP1BP3 DST STXBP1 UMODL1 ASPM BSN ROCK2 ANK2 SLC25A4 DSP CTDSPL2 CNTRL ZFC3H1 ARRB1 MACF1 CFAP74 CCAR2 EIF2AK4 CFAP69 XRCC6 | 4.62e-06 | 1442 | 232 | 26 | 35575683 | |
| Pubmed | 5.08e-06 | 100 | 232 | 7 | 26073538 | ||
| Pubmed | 5.77e-06 | 6 | 232 | 3 | 22318609 | ||
| Pubmed | 5.77e-06 | 6 | 232 | 3 | 17500066 | ||
| Pubmed | 5.77e-06 | 6 | 232 | 3 | 27698114 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK17 SEC24A DDX6 PTK2B PTPN3 DST ALMS1 SYNJ1 SEC24B KIF14 AP1M1 DSP MINK1 SRGAP2 VIRMA LIMK1 MACF1 NUB1 CEP170B | 6.05e-06 | 861 | 232 | 19 | 36931259 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | PIEZO1 KIF4A RABGAP1 RRM1 CLCC1 NRP1 ITPR2 GLYR1 FAM20B ZDHHC13 ROCK2 ABCC1 L1CAM SLC43A3 ADAM12 ATF6B P2RX5 ABCE1 LNPEP EPHA2 COPS4 LRPAP1 EIF2AK2 | 6.47e-06 | 1201 | 232 | 23 | 35696571 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPS10 KIF4A CHD2 ADAR HP1BP3 ITPR3 KARS1 DST GLYR1 DHCR24 MITF ABCC1 SLC25A4 DSP CTDSPL2 WRN ZFC3H1 JMJD1C TFE3 ELF2 LRIF1 JRKL XRCC6 HELLS | 6.89e-06 | 1294 | 232 | 24 | 30804502 |
| Pubmed | ACACB CHD2 ITPR3 STXBP1 BSN TARBP1 USP24 MUC16 NR4A3 ADAM30 ZDBF2 VIRMA TFE3 ANKRD36B ABCE1 HELLS | 7.02e-06 | 638 | 232 | 16 | 31182584 | |
| Pubmed | RPS10 KIF4A PSMD6 KARS1 DST ALMS1 GLYR1 KIF14 PIP5K1A C3 DNAJC17 ARRB2 ELF2 LRIF1 XRCC6 HELLS | 8.04e-06 | 645 | 232 | 16 | 25281560 | |
| Pubmed | ABCA1 ADAR ITPR3 ABCC1 ANK2 XK ATF6B JMJD1C TTLL7 LIF DNAJC17 TNFAIP2 | 8.47e-06 | 371 | 232 | 12 | 15747579 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SEC24A LRRC49 PSMD1 RABGAP1 BIRC6 CLCC1 ITPR2 ITPR3 PSMD6 DST ALMS1 ALDH1L2 SEC24B SLC25A4 UFL1 ZDBF2 SLC25A51 RMDN3 ARRB2 CLYBL ABCE1 PRKCD CCAR2 TRAK2 EIF2AK2 XRCC6 | 8.82e-06 | 1496 | 232 | 26 | 32877691 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RPS10 PSMD1 DDX6 HP1BP3 PSMD6 DST DOCK2 COPB1 DSP CNTRL COPS3 EPG5 USP14 RMDN3 ABCE1 MACF1 MYO16 XRCC6 | 9.27e-06 | 807 | 232 | 18 | 30575818 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | KIF4A PSMD1 TUBGCP4 DDX6 TLN2 DOCK2 ROCK2 COPB1 DSP USP24 COPS3 MACF1 TNFAIP2 XRCC6 HELLS | 9.91e-06 | 582 | 232 | 15 | 20467437 |
| Pubmed | 1.01e-05 | 7 | 232 | 3 | 16272887 | ||
| Pubmed | 1.01e-05 | 7 | 232 | 3 | 31430342 | ||
| Pubmed | CDK17 RPS10 PSMD1 CHD2 USP9Y RRM1 KRT80 DDX6 HP1BP3 PSMD6 KARS1 GLYR1 PIP5K1A AP1M1 SLC25A4 COPB1 DSP RADX MACF1 CCAR2 EIF2AK2 XRCC6 | 1.10e-05 | 1153 | 232 | 22 | 29845934 | |
| Pubmed | PSMD1 AK9 RRM1 ADAR HP1BP3 COPB1 UFL1 DIS3 USP14 ZNF716 ABCE1 CCAR2 XRCC6 | 1.22e-05 | 451 | 232 | 13 | 36168627 | |
| Pubmed | RPS10 ADAR HP1BP3 KARS1 GLYR1 AP1M1 C3 COPB1 UFL1 DIS3 MACF1 EIF2AK4 EIF2AK2 CEP170B HELLS | 1.44e-05 | 601 | 232 | 15 | 33658012 | |
| Pubmed | PIEZO1 KARS1 DST PSME4 NBEAL2 DHCR24 FAM20B PAN2 BSN SDK2 UFL1 CWC22 DIS3 EIF2AK4 | 1.47e-05 | 529 | 232 | 14 | 14621295 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | KIF4A ADAR BIRC6 DDX6 HP1BP3 KARS1 GLYR1 ASPM SLC25A4 RADX WRN ZFC3H1 VIRMA MACF1 CCAR2 EIF2AK2 XRCC6 | 1.57e-05 | 759 | 232 | 17 | 35915203 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | SEC24A RPS10 USP25 PSMD1 RABGAP1 RRM1 BIRC6 PSMD6 KARS1 PSME4 AP1M1 ROCK2 COPB1 USP24 COPS3 VPS26A DIS3 USP14 ABCE1 LNPEP COPS4 MACF1 CCAR2 XRCC6 XPO7 | 1.61e-05 | 1455 | 232 | 25 | 22863883 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | GIN1 TRO RPS10 RABGAP1 RRM1 ADAR DDX6 PSMD6 KARS1 AP1M1 TLN2 ROCK2 SLC25A4 COPB1 DSP MACF1 CCAR2 XRCC6 | 1.77e-05 | 847 | 232 | 18 | 35235311 |
| Pubmed | PXK MAP3K5 PSMD6 DST DHCR24 DSP MINK1 COPS3 ZFC3H1 COPS4 CEP170B XRCC6 | 1.83e-05 | 401 | 232 | 12 | 25852190 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPS10 PSMD1 ADAR KRT80 DDX6 HP1BP3 NRP1 ITPR2 ITPR3 PSMD6 DST KIF14 COPB1 DSP UFL1 MACF1 CCAR2 XRCC6 HELLS XPO7 | 2.01e-05 | 1024 | 232 | 20 | 24711643 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | PTK2B STXBP1 SYNJ1 TLN2 IQSEC3 ANK2 MINK1 SRGAP2 MACF1 CEP170B | 2.14e-05 | 281 | 232 | 10 | 28706196 |
| Pubmed | CDK17 PIEZO1 RPS10 RRM1 CLCC1 HP1BP3 ITPR2 ITPR3 CLCN7 GLYR1 ASPM PIP5K1A ANK2 MINK1 UFL1 ZFC3H1 ATF6B DNAJC17 LNPEP EPHA2 COPS4 MACF1 LRPAP1 XRCC6 HELLS | 2.30e-05 | 1487 | 232 | 25 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PDE9A TTC21A PSMD1 CHD2 RABGAP1 CLCC1 HP1BP3 NRP1 GLYR1 PIP5K1A CAB39L ZDHHC13 MINK1 SRGAP2 JMJD1C RANBP17 USP14 NADSYN1 ARRB1 ARRB2 MACF1 EIF2AK4 CFAP69 CEP170B XPO7 | 2.36e-05 | 1489 | 232 | 25 | 28611215 |
| Pubmed | CDK17 USP25 PSMD1 ITPR3 PSMD6 DST USP24 PDPK2P USP14 COPS4 MACF1 NUB1 XRCC6 | 2.39e-05 | 481 | 232 | 13 | 28190767 | |
| Pubmed | RIPOR2 PSMD1 MAP3K5 PTPN3 DST DSP CNTRL PPP1R13B RMDN3 ARRB1 ARRB2 MACF1 LRPAP1 | 2.66e-05 | 486 | 232 | 13 | 20936779 | |
| Pubmed | RPS10 PSMD1 RRM1 ADAR DDX6 PSMD6 KARS1 AP1M1 COPB1 USP24 UFL1 DIS3 CCAR2 XRCC6 HELLS | 2.88e-05 | 638 | 232 | 15 | 33239621 | |
| Pubmed | SEC24A RABGAP1 CLCC1 ITPR3 DST CLCN7 SEC24B ROCK2 SLC25A4 DSP UFL1 ZDBF2 USP14 RMDN3 | 3.20e-05 | 568 | 232 | 14 | 37774976 | |
| Pubmed | MYOM1 PSMD1 CHD2 BIRC6 MAP3K5 KARS1 DST ALMS1 ANK2 DSP JMJD1C MACF1 XRCC6 | 3.35e-05 | 497 | 232 | 13 | 23414517 | |
| Pubmed | ACACB SEC24A LRRC49 RPS10 PSMD1 HP1BP3 PSMD6 DST ALMS1 GLYR1 SEC24B MITF COPB1 RADX PPP1R13B JMJD1C TFE3 CSTF1 ELF1 CCAR2 ELF2 LRIF1 XRCC6 HELLS | 3.44e-05 | 1429 | 232 | 24 | 35140242 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RPS10 PSMD1 RRM1 BIRC6 DDX6 PSMD6 KARS1 PSME4 DHCR24 AP1M1 DDX12P SLC25A4 COPB1 DSP RADX DIS3 ABCE1 CSTF1 CCAR2 NUB1 XRCC6 HELLS | 4.05e-05 | 1257 | 232 | 22 | 37317656 |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 4.34e-05 | 139 | 232 | 7 | 25476789 | |
| Pubmed | 4.35e-05 | 58 | 232 | 5 | 19013454 | ||
| Pubmed | Ask1 regulates murine platelet granule secretion, thromboxane A2 generation, and thrombus formation. | 4.43e-05 | 2 | 232 | 2 | 28028021 | |
| Pubmed | ARRB2 (β-Arrestin-2) Deficiency Alters Fluid Homeostasis and Blood Pressure Regulation. | 4.43e-05 | 2 | 232 | 2 | 36215165 | |
| Pubmed | Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. | 4.43e-05 | 2 | 232 | 2 | 17618287 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 16192283 | ||
| Pubmed | Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells. | 4.43e-05 | 2 | 232 | 2 | 30575730 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 11002341 | ||
| Pubmed | Carbachol stimulates TYR phosphorylation and association of PKCdelta and PYK2 in pancreas. | 4.43e-05 | 2 | 232 | 2 | 11352632 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 9668034 | ||
| Pubmed | Metabolic effects of skeletal muscle-specific deletion of beta-arrestin-1 and -2 in mice. | 4.43e-05 | 2 | 232 | 2 | 31622341 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 37820892 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 12582207 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 26927499 | ||
| Pubmed | Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. | 4.43e-05 | 2 | 232 | 2 | 8081734 | |
| Pubmed | Deficiency of β-Arrestin 2 in Dendritic Cells Contributes to Autoimmune Diseases. | 4.43e-05 | 2 | 232 | 2 | 30541881 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 25134464 | ||
| Pubmed | Regulation of lipopolysaccharide-induced inflammatory response and endotoxemia by beta-arrestins. | 4.43e-05 | 2 | 232 | 2 | 20589830 | |
| Pubmed | β-Arrestin2 mediates the initiation and progression of myeloid leukemia. | 4.43e-05 | 2 | 232 | 2 | 22773819 | |
| Pubmed | The role of PIEZO ion channels in the musculoskeletal system. | 4.43e-05 | 2 | 232 | 2 | 36717101 | |
| Pubmed | Unique Roles of β-Arrestin in GPCR Trafficking Revealed by Photoinducible Dimerizers. | 4.43e-05 | 2 | 232 | 2 | 29330504 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 32906142 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 35619555 | ||
| Pubmed | TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis. | 4.43e-05 | 2 | 232 | 2 | 28655204 | |
| Pubmed | A Plug-and-Latch Mechanism for Gating the Mechanosensitive Piezo Channel. | 4.43e-05 | 2 | 232 | 2 | 32142647 | |
| Pubmed | Conserved intermolecular salt bridge required for activation of protein kinases PKR, GCN2, and PERK. | 4.43e-05 | 2 | 232 | 2 | 17202131 | |
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 16790614 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 21191175 | ||
| Pubmed | 4.43e-05 | 2 | 232 | 2 | 35276608 | ||
| Pubmed | β-arrestins negatively control human adrenomedullin type 1-receptor internalization. | 4.43e-05 | 2 | 232 | 2 | 28427767 | |
| Pubmed | Beta-arrestins 1 and 2 are associated with nicotine dependence in European American smokers. | 4.43e-05 | 2 | 232 | 2 | 17579607 | |
| Interaction | GRK2 interactions | 9.07e-07 | 119 | 225 | 10 | int:GRK2 | |
| Interaction | MYH9 interactions | USP45 MYOM1 RPS10 USP25 PSMD1 ITGB3 ITPR2 ITPR3 PSMD6 FBXO25 DST CLCN2 PAN2 KIF14 PIP5K1A CTDSPL2 UFL1 COPS3 VIRMA USP14 ARRB1 ARRB2 COPS4 MACF1 XRCC6 | 1.25e-06 | 754 | 225 | 25 | int:MYH9 |
| Interaction | YWHAG interactions | CDK17 RIPOR2 SEC24A PSMD1 RRM1 DDX6 MAP3K5 PTPN3 DST ALMS1 SYNJ1 SEC24B MITF KIF14 AP1M1 COPB1 DSP MINK1 USP24 SRGAP2 CWC22 VIRMA TFE3 TTLL7 RMDN3 ARRB1 ARRB2 MACF1 PRKCD NUB1 CEP170B | 2.43e-05 | 1248 | 225 | 31 | int:YWHAG |
| Interaction | PSMC3 interactions | PSMD1 PTCH1 DDX6 MAP3K5 ITPR2 PSMD6 FBXO25 PSME4 KIF14 UFL1 VIRMA USP14 CCAR2 ELF2 EIF2AK4 LRIF1 | 2.48e-05 | 425 | 225 | 16 | int:PSMC3 |
| Interaction | EED interactions | ACACB SEC24A RPS10 KIF4A PSMD1 CHD2 RRM1 ADAR BIRC6 DDX6 HP1BP3 PSMD6 PTK2B SYNJ1 GLYR1 SEC24B AP1M1 SLC25A4 COPB1 DSP COPS3 CWC22 VIRMA DIS3 USP14 ABCE1 UNC45B MACF1 LRPAP1 CCAR2 CEP170B XRCC6 HELLS XPO7 | 2.88e-05 | 1445 | 225 | 34 | int:EED |
| Interaction | GJA1 interactions | SEC24A RABGAP1 CLCC1 ITPR2 ITPR3 DST STXBP1 SEC24B PIP5K1A C3 ROCK2 ABCC1 SDK2 MINK1 UFL1 LNPEP EPHA2 MACF1 KCTD2 | 3.18e-05 | 583 | 225 | 19 | int:GJA1 |
| Interaction | PSMD2 interactions | SEC24A PSMD1 PTCH1 ITGB3 PSMD6 FBXO25 PSME4 KIF14 ABCC1 COPB1 UFL1 VIRMA USP14 CCAR2 NUB1 LRIF1 | 3.28e-05 | 435 | 225 | 16 | int:PSMD2 |
| Interaction | SIRT7 interactions | RPS10 KIF4A PSMD1 CHD2 BIRC6 HP1BP3 ITPR3 KARS1 DST GLYR1 KIF14 COPB1 DSP USP24 VIRMA DIS3 ABCE1 COPS4 MACF1 CCAR2 XRCC6 XPO7 | 3.30e-05 | 744 | 225 | 22 | int:SIRT7 |
| Interaction | PHF21A interactions | ACACB LRRC49 PSMD1 RABGAP1 BIRC6 DST ALMS1 SYNJ1 KIF14 DSP USP24 ZDBF2 JMJD1C ARRB2 | 3.36e-05 | 343 | 225 | 14 | int:PHF21A |
| Interaction | PGBD5 interactions | 4.65e-05 | 7 | 225 | 3 | int:PGBD5 | |
| Interaction | CLTC interactions | RPS10 USP25 PTCH1 RRM1 ADAR ITGB3 SYNJ1 SEC24B PAN2 KIF14 CNTRL UFL1 VIRMA TFE3 BTBD3 ARRB1 ARRB2 EPHA2 CCAR2 XRCC6 | 4.90e-05 | 655 | 225 | 20 | int:CLTC |
| Interaction | EDNRB interactions | 7.01e-05 | 39 | 225 | 5 | int:EDNRB | |
| Interaction | IMPDH2 interactions | LRRC49 PSMD1 PTCH1 PSMD6 FBXO25 ALMS1 SYNJ1 KIF14 PIP5K1A DSP UFL1 VIRMA USP14 LIMK1 SLC25A44 | 8.07e-05 | 420 | 225 | 15 | int:IMPDH2 |
| Interaction | AP2B1 interactions | PSMD1 TUBGCP4 ALMS1 SYNJ1 KIF14 AP1M1 UFL1 VIRMA ARRB1 ARRB2 LNPEP EPHA2 CEP170B XPO7 | 8.28e-05 | 373 | 225 | 14 | int:AP2B1 |
| Interaction | ATP2A1 interactions | SEC24A PIEZO1 CLCC1 ITPR2 ITPR3 CLCN7 DHCR24 SEC24B KIF14 SLC25A17 ABCC1 UFL1 FAR2 LNPEP PRKCD | 8.73e-05 | 423 | 225 | 15 | int:ATP2A1 |
| Interaction | CGAS interactions | USP25 CHD2 HP1BP3 CLCN7 KIF14 DDX60L DDX60 UFL1 VIRMA ABCE1 CAPN7 LRIF1 MX2 | 8.91e-05 | 329 | 225 | 13 | int:CGAS |
| Interaction | CDC5L interactions | RPS10 KIF4A PSMD1 TUBGCP4 DDX6 DST KIF14 TLN2 ROCK2 COPB1 DSP WRN USP24 PPP1R13B UFL1 ZDBF2 CWC22 VIRMA DNAJC17 MACF1 TNFAIP2 EIF2AK2 HELLS | 9.20e-05 | 855 | 225 | 23 | int:CDC5L |
| Interaction | NR3C1 interactions | ACACB CHD2 ITPR3 KARS1 STXBP1 C3 BSN TARBP1 FNIP2 ABCC1 SLC25A4 DSP USP24 MUC16 NR4A3 ADAM30 ZDBF2 VIRMA JMJD1C TFE3 ANKRD36B ARRB1 ABCE1 LRIF1 HELLS | 9.50e-05 | 974 | 225 | 25 | int:NR3C1 |
| Interaction | NUP155 interactions | SEC24A LRRC49 CLCC1 ITPR2 ITPR3 ALMS1 CLCN7 DHCR24 SEC24B KIF14 C3 DDX60 UFL1 VIRMA RMDN3 EPHA2 | 9.73e-05 | 477 | 225 | 16 | int:NUP155 |
| Interaction | UBA1 interactions | TUBGCP4 ITGB3 KARS1 MYLK4 KIF14 AP1M1 TRPM8 VIRMA TFE3 USP14 LRPAP1 XRCC6 HELLS XPO7 | 1.01e-04 | 380 | 225 | 14 | int:UBA1 |
| Interaction | VIM interactions | RPS10 PSMD1 TUBGCP4 PTCH1 ITGB3 FBXO25 KARS1 CLCN2 SYNJ1 PAN2 KIF14 ROCK2 DSP CNTRL UFL1 VIRMA TFE3 USP14 ARRB1 ARRB2 ABCE1 LRIF1 | 1.03e-04 | 804 | 225 | 22 | int:VIM |
| Interaction | YWHAH interactions | CDK17 SEC24A DDX6 MAP3K5 PTPN3 DST ALMS1 SYNJ1 SEC24B MITF KIF14 DSP CNTRL MINK1 SRGAP2 CWC22 VIRMA TFE3 TTLL7 RMDN3 ARRB1 ARRB2 ABCE1 MACF1 CCAR2 NUB1 CEP170B | 1.07e-04 | 1102 | 225 | 27 | int:YWHAH |
| Interaction | PSMC5 interactions | PSMD1 PTCH1 BIRC6 MAP3K5 PSMD6 FBXO25 PSME4 ASPM PAN2 KIF14 ABCC1 UFL1 VIRMA USP14 CCAR2 NUB1 | 1.15e-04 | 484 | 225 | 16 | int:PSMC5 |
| Interaction | MAGEA9 interactions | ITPR2 ITPR3 STXBP1 SYNJ1 ASPM KIF14 ZDBF2 ZFC3H1 EIF2AK4 HELLS | 1.21e-04 | 208 | 225 | 10 | int:MAGEA9 |
| Interaction | KCNA3 interactions | SEC24A PSMD1 CHD2 RRM1 CLCC1 DDX6 PSMD6 DST SEC24B TLN2 BSN ROCK2 ANK2 COPB1 DSP MINK1 USP24 JMJD1C ABCE1 EPHA2 MACF1 EIF2AK4 XRCC6 | 1.21e-04 | 871 | 225 | 23 | int:KCNA3 |
| Interaction | AGAP2 interactions | 1.31e-04 | 210 | 225 | 10 | int:AGAP2 | |
| Interaction | PSMC2 interactions | PSMD1 PTCH1 DDX6 MAP3K5 PSMD6 PSME4 KIF14 ROCK2 UFL1 VPS26A VIRMA USP14 ABCE1 CCAR2 | 1.43e-04 | 393 | 225 | 14 | int:PSMC2 |
| GeneFamily | Ubiquitin specific peptidases | 7.62e-06 | 56 | 153 | 6 | 366 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.23e-05 | 8 | 153 | 3 | 939 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 2.12e-04 | 3 | 153 | 2 | 297 | |
| GeneFamily | DNA helicases | 3.70e-04 | 17 | 153 | 3 | 1167 | |
| GeneFamily | Classical arrestins | 4.22e-04 | 4 | 153 | 2 | 1312 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 8.39e-04 | 50 | 153 | 4 | 1293 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.50e-03 | 27 | 153 | 3 | 47 | |
| GeneFamily | Fibronectin type III domain containing | 2.42e-03 | 160 | 153 | 6 | 555 | |
| GeneFamily | COP9 signalosome | 2.46e-03 | 9 | 153 | 2 | 932 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.46e-03 | 9 | 153 | 2 | 1234 | |
| GeneFamily | Chloride voltage-gated channels | 3.06e-03 | 10 | 153 | 2 | 302 | |
| GeneFamily | Ankyrin repeat domain containing | 4.59e-03 | 242 | 153 | 7 | 403 | |
| GeneFamily | DEAD-box helicases | 5.36e-03 | 42 | 153 | 3 | 499 | |
| GeneFamily | Proteasome | 5.72e-03 | 43 | 153 | 3 | 690 | |
| Coexpression | HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | ARMH1 KARS1 SERPINB9 PAN2 DDX60L TARBP1 DDX60 CNTRL CCRL2 SLC43A3 EPG5 LIMK1 SMTNL1 NUB1 EIF2AK2 | 2.50e-06 | 394 | 231 | 15 | M40996 |
| Coexpression | DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS | CFAP251 TTC21A TSPAN19 AK9 ODAD4 CFAP47 IQCH CFAP43 TMEM232 CFAP74 CFAP69 ANKFN1 | 2.72e-05 | 317 | 231 | 12 | M40298 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CDK17 RIPOR2 PIEZO1 USP25 CHD2 ADAM8 IL18RAP ADAR BIRC6 DDX6 ITPR2 PTK2B SERPINB9 NBEAL2 AP1M1 DOCK2 COPB1 CNTRL USP24 VPS26A ZFC3H1 JMJD1C EPG5 ARRB2 P2RX5 LNPEP MACF1 ELF1 XRCC6 | 5.55e-05 | 1492 | 231 | 29 | M40023 |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | TTC21A TSPAN19 AK9 ODAD4 ALMS1 PZP CFAP47 IQCH USP24 CFAP43 TTLL7 TMEM232 MACF1 CFAP69 | 6.29e-05 | 459 | 231 | 14 | M39136 |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN | 6.70e-05 | 197 | 231 | 9 | M6075 | |
| Coexpression | GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN | 7.24e-05 | 199 | 231 | 9 | M2921 | |
| Coexpression | GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP | 7.52e-05 | 200 | 231 | 9 | M7135 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN | KIF4A RRM1 ITPR2 DHCR24 KIF14 ZDHHC13 VPS26A JMJD1C ANKRD36B | 7.52e-05 | 200 | 231 | 9 | M8869 |
| Coexpression | GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN | ADAR PTK2B SERPINB9 STXBP1 DDX60 CCRL2 SLC25A44 TNFAIP2 EIF2AK2 | 7.52e-05 | 200 | 231 | 9 | M7336 |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP | 7.52e-05 | 200 | 231 | 9 | M8690 | |
| Coexpression | GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN | 7.52e-05 | 200 | 231 | 9 | M6372 | |
| Coexpression | GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP | 7.52e-05 | 200 | 231 | 9 | M5087 | |
| Coexpression | GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP | 7.52e-05 | 200 | 231 | 9 | M9030 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | MAP3K5 PTPN3 DST KIF14 USP24 ZFC3H1 BTBD3 SLC25A44 PRKCD ELF1 ELF2 | 7.81e-05 | 300 | 231 | 11 | M8702 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 8.09e-05 | 250 | 231 | 10 | M11318 | |
| Coexpression | ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP | 9.15e-05 | 119 | 231 | 7 | M41139 | |
| CoexpressionAtlas | alpha beta T cells, T.8.TI.B16, 4- 8+ TCR+ 45+, B16 Melanoma Tumor, avg-2 | ATP8B4 KIF4A PTCH1 RRM1 ADAM8 IL18RAP NRP1 SERPINB9 DHCR24 ASPM KIF14 NR4A3 MX2 HELLS | 2.00e-05 | 359 | 216 | 14 | GSM605773_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | TRO KIF4A PSMD1 CHD2 ITPR2 STXBP1 SEC24B FNIP2 COPB1 CTDSPL2 USP24 JMJD1C RMDN3 PTCD2 SLC25A44 MACF1 CFAP74 EIF2AK4 | 2.01e-05 | 564 | 216 | 18 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | CFAP251 TSPAN19 AK9 ODAD4 BBS9 CFAP47 IQCH CFAP43 TMEM232 CFAP74 CFAP69 ANKFN1 | 4.60e-10 | 193 | 232 | 12 | ad58f5080e0ba65c845056ea6b79037b636e9c64 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | CHD2 ADAR BIRC6 DDX6 DDX60L DDX60 ZFC3H1 JMJD1C MACF1 NUB1 EIF2AK2 MX2 | 6.92e-10 | 200 | 232 | 12 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | CHD2 ADAR DST DDX60L DSP DDX60 JMJD1C NUB1 TNFAIP2 EIF2AK2 MX2 | 3.53e-09 | 183 | 232 | 11 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | CFAP251 TTC21A LRRC49 TSPAN19 PZP CFAP47 CFAP43 TMEM232 CFAP74 CFAP69 ANKFN1 | 3.96e-09 | 185 | 232 | 11 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | CFAP251 TSPAN19 AK9 ODAD4 CFAP47 IQCH CFAP43 TMEM232 CFAP74 CFAP69 ANKFN1 | 5.83e-09 | 192 | 232 | 11 | 354adc1354bf596fbc60dd45c0169688e6f45165 |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | CFAP251 TSPAN19 AK9 ODAD4 CFAP47 IQCH CFAP43 TMEM232 CFAP74 CFAP69 ANKFN1 | 6.16e-09 | 193 | 232 | 11 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFAP251 TTC21A TSPAN19 AK9 PZP MUC16 CFAP43 CFAP74 CFAP69 ANKFN1 | 2.14e-08 | 169 | 232 | 10 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.14e-08 | 176 | 232 | 10 | dc4e939a07bad21ab36181f9588df3fa662f9a92 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | BIRC6 DDX6 HP1BP3 ROCK2 CTDSPL2 CNTRL JMJD1C LNPEP MACF1 ELF1 | 4.78e-08 | 184 | 232 | 10 | 1154a5ad7b8512272b7476f949ddac350910bfb7 |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | CFAP251 TSPAN19 AK9 ODAD4 CFAP47 IQCH CFAP43 TMEM232 CFAP74 ANKFN1 | 6.16e-08 | 189 | 232 | 10 | 3e77883db34722b9ce0a03ea74caefc92dc7feff |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CFAP251 TSPAN19 CFAP47 IQCH MUC16 CFAP43 TMEM232 CFAP74 CFAP69 ANKFN1 | 6.80e-08 | 191 | 232 | 10 | 1c528f72c9ef3ef3a850b05e4a9715190832270c |
| ToppCell | Mild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.80e-08 | 191 | 232 | 10 | 382686d62f7b8576c44bb9726a4e10dc26fd348e | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CFAP251 TSPAN19 CFAP47 IQCH MUC16 CFAP43 TMEM232 CFAP74 CFAP69 ANKFN1 | 6.80e-08 | 191 | 232 | 10 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CFAP251 TSPAN19 CFAP47 IQCH MUC16 CFAP43 TMEM232 CFAP74 CFAP69 ANKFN1 | 6.80e-08 | 191 | 232 | 10 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | CFAP251 TSPAN19 CFAP47 IQCH MUC16 CFAP43 TMEM232 CFAP74 CFAP69 ANKFN1 | 7.14e-08 | 192 | 232 | 10 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFAP251 TTC21A TSPAN19 AK9 ODAD4 CFAP47 MUC16 CFAP43 CFAP74 CFAP69 | 7.87e-08 | 194 | 232 | 10 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 8.66e-08 | 196 | 232 | 10 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.98e-08 | 199 | 232 | 10 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.98e-08 | 199 | 232 | 10 | e7faf7d0cb43cf93149c446e5f718f84fa85477c | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 1.05e-07 | 200 | 232 | 10 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CFAP251 TTC21A TSPAN19 ODAD4 PZP CFAP47 CFAP43 TMEM232 CFAP74 ANKFN1 | 1.05e-07 | 200 | 232 | 10 | 31d75c26055177d656df1fbb10b764cebd61e122 |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CFAP251 TTC21A TSPAN19 ODAD4 PZP CFAP47 CFAP43 TMEM232 CFAP74 ANKFN1 | 1.05e-07 | 200 | 232 | 10 | e1dce91c6c531bb212002a14705e496d77ad3490 |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | CFAP251 TTC21A TSPAN19 AK9 ODAD4 MUC16 CFAP43 TMEM232 CFAP69 | 2.44e-07 | 167 | 232 | 9 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.62e-07 | 175 | 232 | 9 | 3b5346fba617292de71963b6175e85a4f182fe30 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.59e-07 | 180 | 232 | 9 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | CFAP251 TSPAN19 ODAD4 CFAP47 IQCH CFAP43 TMEM232 CFAP74 ANKFN1 | 4.81e-07 | 181 | 232 | 9 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.03e-07 | 182 | 232 | 9 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | CFAP251 TSPAN19 ODAD4 CFAP47 MUC16 CFAP43 TMEM232 CFAP74 ANKFN1 | 5.77e-07 | 185 | 232 | 9 | 18a40f0a338aa398d81384b5159fb80ce8a2020c |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.60e-07 | 188 | 232 | 9 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.90e-07 | 189 | 232 | 9 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.90e-07 | 189 | 232 | 9 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | CFAP251 TSPAN19 ODAD4 CFAP47 CFAP43 TMEM232 CFAP74 CFAP69 ANKFN1 | 6.90e-07 | 189 | 232 | 9 | b679920f0993e917dd86da082113bfbd85ea1ca5 |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.21e-07 | 190 | 232 | 9 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-07 | 192 | 232 | 9 | 690cf19e9b0b2ada80097c63eae827529aa5b6f3 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-07 | 192 | 232 | 9 | 3d6c4c5847ca1e44fa380403d25af45d5b51ee9b | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | CFAP251 TSPAN19 CFAP47 IQCH CFAP43 TMEM232 CFAP74 CFAP69 ANKFN1 | 7.87e-07 | 192 | 232 | 9 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-07 | 192 | 232 | 9 | e0412964a3ee1bf3c0ef64f9a6f20f7e7835701e | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-07 | 192 | 232 | 9 | b5871247a5f3e970fa05b33fff21bef9d2ab5741 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | CFAP251 LRRC49 TSPAN19 CFAP47 CFAP43 TMEM232 CFAP74 CFAP69 ANKFN1 | 8.58e-07 | 194 | 232 | 9 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.58e-07 | 194 | 232 | 9 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | CFAP251 TSPAN19 ODAD4 CFAP47 MUC16 CFAP43 TMEM232 CFAP74 CFAP69 | 8.58e-07 | 194 | 232 | 9 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 8.96e-07 | 195 | 232 | 9 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 8.96e-07 | 195 | 232 | 9 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.35e-07 | 196 | 232 | 9 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | Mild-CD4+_T_activated|Mild / Disease group and Cell class | 9.35e-07 | 196 | 232 | 9 | daa1c3322d81e649161e889e1d78451d2d425d09 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 9.35e-07 | 196 | 232 | 9 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.35e-07 | 196 | 232 | 9 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.75e-07 | 197 | 232 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | CFAP251 LRRC49 TSPAN19 AK9 CFAP47 CFAP43 TMEM232 CFAP74 CFAP69 | 9.75e-07 | 197 | 232 | 9 | 6865f4831eb23794fb88a8649d48d497bbae3f44 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.75e-07 | 197 | 232 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 9.75e-07 | 197 | 232 | 9 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.02e-06 | 198 | 232 | 9 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-06 | 199 | 232 | 9 | e245851a5bddf56f7e13a7fb7c5fda2fd275dae3 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | CFAP251 TTC21A TSPAN19 AK9 ODAD4 CFAP47 CFAP43 CFAP74 CFAP69 | 1.11e-06 | 200 | 232 | 9 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.11e-06 | 200 | 232 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CFAP251 TSPAN19 ODAD4 PZP CFAP47 CFAP43 TMEM232 CFAP74 ANKFN1 | 1.11e-06 | 200 | 232 | 9 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CFAP251 TSPAN19 ODAD4 PZP CFAP47 CFAP43 TMEM232 CFAP74 ANKFN1 | 1.11e-06 | 200 | 232 | 9 | 12bc7d95c4166d12487081a76d210b7abe5991b0 |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.11e-06 | 200 | 232 | 9 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.11e-06 | 200 | 232 | 9 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-06 | 160 | 232 | 8 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-06 | 160 | 232 | 8 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.54e-06 | 165 | 232 | 8 | ec16a4979b3f203c9f66ed387a7a17bf3a1d3f86 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.17e-06 | 170 | 232 | 8 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.27e-06 | 177 | 232 | 8 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.64e-06 | 179 | 232 | 8 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.64e-06 | 179 | 232 | 8 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.03e-06 | 181 | 232 | 8 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.03e-06 | 181 | 232 | 8 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.03e-06 | 181 | 232 | 8 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.03e-06 | 181 | 232 | 8 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 5.24e-06 | 182 | 232 | 8 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.24e-06 | 182 | 232 | 8 | 08aff7112c9dac0ef5540300516a604782b21169 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 182 | 232 | 8 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.46e-06 | 183 | 232 | 8 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.46e-06 | 183 | 232 | 8 | 310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.91e-06 | 185 | 232 | 8 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.15e-06 | 186 | 232 | 8 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.39e-06 | 187 | 232 | 8 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.39e-06 | 187 | 232 | 8 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.39e-06 | 187 | 232 | 8 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.65e-06 | 188 | 232 | 8 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.65e-06 | 188 | 232 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 6.65e-06 | 188 | 232 | 8 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.91e-06 | 189 | 232 | 8 | aba941ba6ce7702418b3f470bde573d123c4aade | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 6.91e-06 | 189 | 232 | 8 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-06 | 189 | 232 | 8 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.91e-06 | 189 | 232 | 8 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.18e-06 | 190 | 232 | 8 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.18e-06 | 190 | 232 | 8 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.47e-06 | 191 | 232 | 8 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.47e-06 | 191 | 232 | 8 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.47e-06 | 191 | 232 | 8 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.47e-06 | 191 | 232 | 8 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 7.47e-06 | 191 | 232 | 8 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.76e-06 | 192 | 232 | 8 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-06 | 193 | 232 | 8 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 8.06e-06 | 193 | 232 | 8 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-06 | 193 | 232 | 8 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.06e-06 | 193 | 232 | 8 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-06 | 193 | 232 | 8 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| Drug | Nicardipine hydrochloride [54527-84-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A | RIPOR2 TRO PTCH1 PTK2B CLCN7 GLYR1 NOS1 NAALAD2 ADAM12 STK16 LIMK1 CFAP74 TNFAIP2 | 1.13e-07 | 196 | 231 | 13 | 5397_UP |
| Disease | X-11787 measurement | 2.45e-05 | 8 | 227 | 3 | EFO_0021258 | |
| Disease | epilepsy (implicated_via_orthology) | 4.05e-05 | 163 | 227 | 8 | DOID:1826 (implicated_via_orthology) | |
| Disease | lymphocyte count | RIPOR2 PIEZO1 GPR87 RRM1 IL18RAP ITPR2 HAVCR1 SERPINB9 PSME4 ALMS1 UMODL1 AP1M1 C3 DDX60L FNIP2 DOCK2 ROCK2 ABCC1 MINK1 SLC43A3 RAB40A JMJD1C ARRB2 DNAH17 ELF1 KCTD2 | 6.64e-05 | 1464 | 227 | 26 | EFO_0004587 |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.54e-04 | 14 | 227 | 3 | DOID:10976 (biomarker_via_orthology) | |
| Disease | lysosomal storage disease (implicated_via_orthology) | 2.34e-04 | 16 | 227 | 3 | DOID:3211 (implicated_via_orthology) | |
| Disease | WAARDENBURG SYNDROME, TYPE 4A | 3.50e-04 | 4 | 227 | 2 | C1848519 | |
| Disease | alcoholic cardiomyopathy (biomarker_via_orthology) | 3.50e-04 | 4 | 227 | 2 | DOID:12935 (biomarker_via_orthology) | |
| Disease | hypertension (biomarker_via_orthology) | 3.96e-04 | 227 | 227 | 8 | DOID:10763 (biomarker_via_orthology) | |
| Disease | cortical thickness | RIPOR2 LRRC49 RABGAP1 PTCH1 BBS9 PXK NRP1 UMODL1 GLYR1 MITF FNIP2 SRGAP2 ADAM12 JMJD1C HHIP FAR2 CLYBL MACF1 ANKFN1 MYO16 | 4.11e-04 | 1113 | 227 | 20 | EFO_0004840 |
| Disease | Cis-4-decenoyl carnitine measurement | 5.80e-04 | 5 | 227 | 2 | EFO_0022091 | |
| Disease | Gait, Unsteady | 5.80e-04 | 5 | 227 | 2 | C0231686 | |
| Disease | Waardenburg Syndrome Type 2 | 5.80e-04 | 5 | 227 | 2 | C2700265 | |
| Disease | Waardenburg syndrome (is_implicated_in) | 5.80e-04 | 5 | 227 | 2 | DOID:9258 (is_implicated_in) | |
| Disease | portal hypertension (is_marker_for) | 8.66e-04 | 6 | 227 | 2 | DOID:10762 (is_marker_for) | |
| Disease | Waardenburg Syndrome | 8.66e-04 | 6 | 227 | 2 | C3266898 | |
| Disease | beta-citrylglutamate measurement | 1.21e-03 | 7 | 227 | 2 | EFO_0800060 | |
| Disease | pulmonary venoocclusive disease (biomarker_via_orthology) | 1.21e-03 | 7 | 227 | 2 | DOID:5453 (biomarker_via_orthology) | |
| Disease | osteopetrosis (implicated_via_orthology) | 1.21e-03 | 7 | 227 | 2 | DOID:13533 (implicated_via_orthology) | |
| Disease | APOE carrier status, dementia | 1.34e-03 | 62 | 227 | 4 | EFO_0007659, MONDO_0001627 | |
| Disease | basal cell carcinoma (is_marker_for) | 1.60e-03 | 8 | 227 | 2 | DOID:2513 (is_marker_for) | |
| Disease | cis-4-decenoylcarnitine (C10:1) measurement | 1.60e-03 | 8 | 227 | 2 | EFO_0800311 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.72e-03 | 31 | 227 | 3 | EFO_0022249 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.96e-03 | 291 | 227 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | nephronophthisis (implicated_via_orthology) | 2.05e-03 | 9 | 227 | 2 | DOID:12712 (implicated_via_orthology) | |
| Disease | underweight body mass index status | 2.05e-03 | 9 | 227 | 2 | EFO_0005936 | |
| Disease | octanoylcarnitine measurement | 2.05e-03 | 9 | 227 | 2 | EFO_0021042 | |
| Disease | membranous glomerulonephritis (implicated_via_orthology) | 2.05e-03 | 9 | 227 | 2 | DOID:10976 (implicated_via_orthology) | |
| Disease | platelet-to-lymphocyte ratio | 2.11e-03 | 363 | 227 | 9 | EFO_0008446 | |
| Disease | Cleft palate | 2.21e-03 | 71 | 227 | 4 | HP_0000175 | |
| Disease | brain ischemia (implicated_via_orthology) | 2.45e-03 | 35 | 227 | 3 | DOID:2316 (implicated_via_orthology) | |
| Disease | white matter hyperintensity measurement | 2.46e-03 | 302 | 227 | 8 | EFO_0005665 | |
| Disease | interventricular septum thickness | 2.55e-03 | 10 | 227 | 2 | EFO_0009287 | |
| Disease | coffee consumption measurement | 2.93e-03 | 182 | 227 | 6 | EFO_0006781 | |
| Disease | N-acetylhistidine measurement | 3.10e-03 | 11 | 227 | 2 | EFO_0800022 | |
| Disease | Myoclonic Astatic Epilepsy | 3.10e-03 | 11 | 227 | 2 | C0393702 | |
| Disease | venous thromboembolism | CDK17 NUGGC TSPAN19 ITPR3 SERPINB9 CCR4 ABCC1 ANK2 PIEZO2 CATSPERB | 3.15e-03 | 460 | 227 | 10 | EFO_0004286 |
| Disease | Colorectal Carcinoma | ABCA1 GPR87 DCC SCNN1B PAN2 PZP ABCC1 ANK2 WRN POSTN GMCL2 HHIP ABCE1 | 3.26e-03 | 702 | 227 | 13 | C0009402 |
| Disease | Alzheimer's disease (is_implicated_in) | 3.62e-03 | 132 | 227 | 5 | DOID:10652 (is_implicated_in) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 3.70e-03 | 12 | 227 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Behavior Disorders | 3.70e-03 | 12 | 227 | 2 | C0004930 | |
| Disease | Mental disorders | 3.70e-03 | 12 | 227 | 2 | C0004936 | |
| Disease | Abruptio Placentae | 3.70e-03 | 12 | 227 | 2 | EFO_1001754 | |
| Disease | decanoylcarnitine measurement | 3.70e-03 | 12 | 227 | 2 | EFO_0021039 | |
| Disease | Mental Disorders, Severe | 3.70e-03 | 12 | 227 | 2 | C4046029 | |
| Disease | Diagnosis, Psychiatric | 3.70e-03 | 12 | 227 | 2 | C0376338 | |
| Disease | smoking cessation | 3.84e-03 | 325 | 227 | 8 | EFO_0004319 | |
| Disease | congestive heart failure (implicated_via_orthology) | 3.86e-03 | 41 | 227 | 3 | DOID:6000 (implicated_via_orthology) | |
| Disease | mitochondrial DNA measurement | 4.06e-03 | 328 | 227 | 8 | EFO_0006312 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 4.24e-03 | 137 | 227 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | Drug-Induced Liver Disease | 4.27e-03 | 404 | 227 | 9 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 4.27e-03 | 404 | 227 | 9 | C3658290 | |
| Disease | Hepatitis, Toxic | 4.27e-03 | 404 | 227 | 9 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 4.27e-03 | 404 | 227 | 9 | C4279912 | |
| Disease | Chemical and Drug Induced Liver Injury | 4.27e-03 | 404 | 227 | 9 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 4.27e-03 | 404 | 227 | 9 | C1262760 | |
| Disease | ventricular enlargement measurement | 4.35e-03 | 13 | 227 | 2 | EFO_0010570 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 4.35e-03 | 13 | 227 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | insulin metabolic clearance rate measurement, glucose homeostasis measurement | 5.05e-03 | 14 | 227 | 2 | EFO_0006830, EFO_0006896 | |
| Disease | Heart Diseases | 5.35e-03 | 46 | 227 | 3 | C0018799 | |
| Disease | diastolic blood pressure, systolic blood pressure | ATP8B4 RIPOR2 LRRC49 PSMD1 ALMS1 TLN2 NAALAD2 ANK2 COPS3 PIEZO2 CLYBL PTCD2 | 6.00e-03 | 670 | 227 | 12 | EFO_0006335, EFO_0006336 |
| Disease | schizophrenia, anorexia nervosa | 6.02e-03 | 48 | 227 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 6.06e-03 | 94 | 227 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | cognitive function measurement, self reported educational attainment | 6.46e-03 | 355 | 227 | 8 | EFO_0004784, EFO_0008354 | |
| Disease | lipid measurement, intermediate density lipoprotein measurement | 6.53e-03 | 96 | 227 | 4 | EFO_0004529, EFO_0008595 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 6.59e-03 | 16 | 227 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 6.59e-03 | 16 | 227 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 7.26e-03 | 99 | 227 | 4 | EFO_0004574, EFO_0008595 | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 7.26e-03 | 99 | 227 | 4 | EFO_0004639, EFO_0008595 | |
| Disease | Antibody Deficiency Syndrome | 7.43e-03 | 17 | 227 | 2 | C0003257 | |
| Disease | glutarylcarnitine (C5-DC) measurement | 7.43e-03 | 17 | 227 | 2 | EFO_0800030 | |
| Disease | MHPG measurement, 5-HIAA measurement | 7.43e-03 | 17 | 227 | 2 | EFO_0005132, EFO_0005133 | |
| Disease | Influenza | 7.53e-03 | 52 | 227 | 3 | C0021400 | |
| Disease | serum IgG glycosylation measurement | BANF2 CHD2 ITGB3 UMODL1 ALDH1L2 DOCK2 WRN EYS ANKFN1 CEP170B | 7.61e-03 | 523 | 227 | 10 | EFO_0005193 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VGLYRQKSNLKVVLT | 1141 | Q5DID0 | |
| RLLLTGVQKRYFEKL | 51 | Q8N1M1 | |
| RLPQLGEKVLVKAAY | 86 | Q8N163 | |
| NYVTKRQSLKLLGEL | 221 | Q9H9S4 | |
| LILRLKLHKNDYGIQ | 971 | Q9HCE0 | |
| RVELLAKKISQLGYS | 346 | P26196 | |
| RRTKLKGNILLDYTL | 101 | Q8NDM7 | |
| LILVKYKGLKRVENI | 61 | O00421 | |
| KLEVLNLSYNLIGKI | 126 | Q7Z7A1 | |
| KDLLYKQLSGRLQLV | 491 | Q7Z7A1 | |
| ILAKVEGQRLVYQFK | 276 | P32519 | |
| GLTYIKIQLVKAEVA | 3261 | Q9NR09 | |
| YIKDLNILGRDLSKT | 386 | Q05D32 | |
| IDLGNSYVLKAKVIR | 736 | Q9H7T0 | |
| KYILVSLILLGKVQQ | 226 | Q9UNS2 | |
| GIKLQVLINLGLVYK | 1306 | Q9P2K8 | |
| RVYFKNKLKLALIGQ | 16 | Q3SY69 | |
| GLESKRLRKYLFQIL | 96 | Q8IVW4 | |
| IKDLVGYDVRQALLK | 246 | Q6PIY5 | |
| FLLIILSYIKIGKNL | 231 | Q9UPC5 | |
| KLGVSIQNLVKVYRD | 896 | O95477 | |
| LYKKRVTNQLLGRKV | 4151 | Q8TCU4 | |
| VYVLDLKGKVLICRN | 6 | Q9BXS5 | |
| LELIKKGYTQQLAFR | 1046 | P01024 | |
| IENKRKVLGKALYLI | 306 | Q9Y2F9 | |
| LAAGFVVYLKRKTLI | 721 | O43184 | |
| IIGNSTLLRIIYKNK | 116 | P24530 | |
| GNSVVVLVLFKYKRL | 56 | P51679 | |
| RAVLRGNLEKLKYLL | 26 | Q8N2N9 | |
| LVKKYRNAVTLAIGD | 801 | Q8TF62 | |
| LYQKLNFRVVLVGLE | 236 | P78325 | |
| LIRNLNVILAKYGLD | 111 | P30533 | |
| QKYVTLKLNDVIRFG | 76 | Q9Y4F5 | |
| ALIIQKYIRAREAGK | 3056 | Q8IZT6 | |
| LLELLQIYREKPGNK | 3346 | Q8IZT6 | |
| SELRERLYGKKIQLN | 311 | Q96KQ4 | |
| NREILGIIVSYKVKV | 311 | P49407 | |
| ANKEVLGILVSYRVK | 311 | P32121 | |
| YLVFINRDKVGLQIL | 861 | Q8TBY9 | |
| DILYARQKIVVIAKA | 221 | Q8N0X4 | |
| YLLKQALKRELNRGV | 201 | Q5SSJ5 | |
| KYLGNLIKGVKRILE | 301 | Q9H2T7 | |
| LNDLSVGYILLKKLV | 616 | Q9H2T7 | |
| YKTTTILLDGQRVKL | 51 | Q8WXH6 | |
| YKTTTILLDGQRVKL | 51 | P0C0E4 | |
| QLTQEIKAKAVGYLI | 1001 | P20742 | |
| QLDIKTGNLLLYEKL | 76 | Q9Y5E4 | |
| IKRIKNLIRGTEAYI | 561 | Q86VS3 | |
| ISNIIVLGIFIKYKE | 41 | O14718 | |
| VLIQFEQLYRKKPGL | 646 | P26045 | |
| EGNTLRKILLNRYFK | 1691 | Q14571 | |
| EYKGKLQVFLRTTLR | 256 | Q14573 | |
| NCGKEKVLFLRLYLL | 331 | Q9Y5A7 | |
| YSFILKVVLRIKAEG | 221 | Q8NGH8 | |
| RVGLVLLLQDYSVKK | 291 | Q6NSI4 | |
| VQSKKNILVDYGLRR | 1446 | O00763 | |
| AKYGSLDVAKLLLQR | 571 | Q01484 | |
| LRQGIDKKIVIYVQQ | 321 | Q9Y3P9 | |
| DLKVIYILVRPKAGQ | 36 | Q96K12 | |
| LLRDIQDKVTTLYKG | 14226 | Q8WXI7 | |
| YLKLRFLIDIGVKFV | 1066 | Q504Q3 | |
| GEEVIQLRSKKYSLL | 276 | P43146 | |
| LRQEVKKLGGYLQLF | 1341 | Q15058 | |
| KLVRNIYKRKGTLQI | 311 | Q9NRZ9 | |
| QLKEKRGVVLLYILL | 351 | O95256 | |
| IASKRIKYLGIQLTR | 761 | O00370 | |
| IKYLGIQLTRDVKDL | 766 | O00370 | |
| DKGLISRIYNELKQI | 1046 | O00370 | |
| ENILKLLKIRQYGIT | 1696 | Q5T1H1 | |
| IYARKGSVLQSIEKI | 496 | Q5T3J3 | |
| IIDFGKIIIYTNNLK | 116 | A6NFK2 | |
| SKGIIYRDLKLDNVL | 466 | Q05655 | |
| LAAKYGQTNLVKLLL | 261 | Q9Y6X6 | |
| GVITNYLLEKSRLVK | 176 | Q9UBC5 | |
| QLLKALKLERDTTGY | 211 | Q9UBC5 | |
| YLKAELSRQLEGILK | 4811 | Q03001 | |
| IRYISGILRKKVEAL | 826 | P46020 | |
| QLLGKYKQIIAVLAQ | 186 | P15018 | |
| NIFKILLQYGILERE | 161 | Q8WXJ9 | |
| VNKKLRQRLLEEYGV | 2431 | Q15652 | |
| YLFTLQIKKDLALGR | 96 | Q6ZUT3 | |
| NVKLALDIEIATYRK | 371 | Q6KB66 | |
| LKYLELGITQRKESL | 2976 | Q9UPA5 | |
| ELILKRLILNFRKGY | 231 | Q9HCG8 | |
| KEKQLVEILFRKGYL | 1271 | Q8IY21 | |
| KLVLVLANLFGRKYI | 1466 | Q5H9U9 | |
| VIGLAVALVLYIRKK | 71 | Q9UK00 | |
| IVVENLAGLKYRVIK | 146 | P51798 | |
| QLLNYLKADRLGKSI | 296 | Q16342 | |
| LYKGLEAKLLQTVLT | 266 | O43808 | |
| SIKTKQIQYGIIRLL | 291 | Q9Y5P1 | |
| KAIYLDIDGRIQKVI | 11 | O76083 | |
| KKYRLITKQGILLVR | 171 | Q8N8M0 | |
| LTKIALRYVALVQEK | 561 | P53618 | |
| DLAGKYRQILEKAIQ | 21 | Q9BT78 | |
| KYIQKDLRLAIALGD | 501 | Q49A26 | |
| KQIKIIDFGLARRYK | 241 | Q86YV6 | |
| VLLIQEKLDGIKTRY | 1656 | O94854 | |
| ISILGDARKKQFRYL | 561 | Q8IUZ0 | |
| LGKVPLKRAFDLINY | 741 | Q9UIQ6 | |
| LAKDQKYRIQRGALI | 376 | P32004 | |
| LGQLKIIKDFYLLGR | 351 | Q9UGJ1 | |
| RFNYVVKLLQLIAKS | 121 | Q8TCJ0 | |
| LRYIQFETLVSGIKK | 101 | O60774 | |
| EYLRSKGLQEKAVLL | 276 | Q9Y4A0 | |
| VYKGRSKLTENLVAL | 206 | Q00537 | |
| RAGNEYLIFQKIIKL | 256 | Q6A1A2 | |
| FIYTIRNKEVKGALR | 286 | Q8NH79 | |
| LVVGIYERIQQKELK | 826 | Q9UPP2 | |
| GIIDILQSYRFVKKL | 401 | Q99755 | |
| FLGLISIDRYLKVVK | 131 | Q9BY21 | |
| LILRLQEYFEKQGVK | 616 | Q3SYG4 | |
| EKQRLLVLSKGLQEY | 1126 | P29475 | |
| ALKNKELRQGLYKVL | 301 | Q8NGI1 | |
| GRVLLHKSLKLYQVI | 766 | O14786 | |
| YLDVKQRLKAAITIR | 246 | P61221 | |
| EVLGRFVIYKKSVLN | 271 | Q9UKF2 | |
| KIGTYQSLKRLFIER | 86 | Q5SVS4 | |
| VLLLLGLASYIRKKQ | 206 | A0A1B0GVN3 | |
| IYLALQKRQILSEGK | 616 | Q96PB1 | |
| ALIYIIGLIADRKFQ | 676 | Q92608 | |
| NKVRKIGELVRYLNT | 711 | P55265 | |
| LAINLVTKGINKAYI | 31 | Q9H503 | |
| AYERRFNKKLITGII | 301 | Q9Y6W3 | |
| KALVAVLREVKYLNF | 676 | Q9UFH2 | |
| LYQNLLAKKRTELVA | 3026 | Q9UFH2 | |
| KAIRLGQKSYLDVIE | 3461 | Q9UFH2 | |
| YIGLINRIAQKKRLT | 101 | P19525 | |
| QGKQLQTRADYLLKL | 1306 | O14647 | |
| VVGKQKDLVQRILYV | 506 | Q9P278 | |
| LKLTQGETLRKLYEQ | 366 | Q15392 | |
| KRIAYSLLGLKDQVN | 956 | P29317 | |
| YGQIKELNEKITRLT | 1101 | P15924 | |
| NIGIKGLIFDRKKVY | 61 | O75936 | |
| KQILYLLEKFVAVLG | 461 | Q92771 | |
| KDVLLRLLQKYGEVL | 191 | Q9NVM6 | |
| ILAKVEGQRLVYQFK | 276 | Q15723 | |
| VLQLIVDAYGKIRSK | 366 | P05106 | |
| ALKYLIGELVSSKIQ | 866 | O95239 | |
| GKVIELRIEALKNYQ | 196 | A0A1B0GTZ2 | |
| GRKYIVENIAKAALL | 21 | E5RQL4 | |
| LKAKRITVSQLLEYG | 2806 | Q8NDH2 | |
| YVVVVKNVGLTLRKL | 906 | Q14289 | |
| VGLKDRQQLYKLIIS | 6 | Q05048 | |
| ENIRAKIYAILGKLD | 716 | A5D8W1 | |
| LQKDLKRYLTRKIGF | 906 | O95487 | |
| LYVLALLKQKAFRTG | 1076 | O95487 | |
| LLVFVLIIRGQSKKY | 1946 | Q58EX2 | |
| TLSRKGIVKLNIYFQ | 486 | P51168 | |
| IILSNKKIGQLIYVA | 2101 | Q6ZTR5 | |
| LLQLRGDVKETYKVI | 1561 | Q9C0B2 | |
| YQETIKKGDLLLNRV | 366 | Q15008 | |
| LGAKRYLLTDNVVKL | 41 | Q8WV60 | |
| ILNYLRHGKLIITKE | 131 | Q14681 | |
| NKKVGLLYRLLQASI | 26 | Q93086 | |
| LLITISGKRNKLRVY | 1071 | Q8N4C8 | |
| LIYTLRNKVVRGAVK | 291 | O76001 | |
| AQKIDKIISLLYGVL | 266 | Q8NGT1 | |
| KTAVIGAVYRKALVI | 396 | P33527 | |
| ILNDIRKARNLYTGK | 276 | Q99683 | |
| RKICTLGLQRIFYLK | 591 | Q92570 | |
| YLNLKRAAILTKLQG | 286 | Q5TCS8 | |
| KREGFQLLLNNKLVY | 256 | Q96TC7 | |
| GVKYLINRLLALIEK | 81 | Q68CJ6 | |
| GTVIIDNKRYLFIQK | 11 | O75716 | |
| FRTLKNLYGKQIIVN | 286 | O43426 | |
| KLIFYDLRGEGVKLQ | 141 | Q15046 | |
| LQKELQRYLTRKIGF | 731 | O95486 | |
| IQKVLFRQQLYGIKT | 51 | Q9H1U9 | |
| LKSEKTVRQLLGELY | 181 | Q96NG3 | |
| LRKKYGVQFILDALR | 1056 | Q6ZNJ1 | |
| IELYRLFGIKQIVIS | 216 | Q9NXP7 | |
| RTTGYQILILKKDQE | 471 | Q8NEA9 | |
| VLLALLGVIIAKKYF | 306 | Q96D42 | |
| KYKQAIGIALETRRL | 146 | Q99460 | |
| VLAYKLLVQTGSRDK | 881 | Q13635 | |
| DVSKVIAYLKRLVNA | 306 | P13521 | |
| AVFLIIKLLYEKGIS | 171 | Q8NBI5 | |
| LIIYSLRNKNVKEAL | 286 | Q8NGP6 | |
| NVLTDIKLGKYRIVY | 626 | Q14191 | |
| VIVVGYESLKKLSLR | 291 | Q96H78 | |
| IQKVLFRQQLYGIKT | 51 | Q3SY17 | |
| RKSLKIIYINSIGEL | 196 | O60811 | |
| RIILLYIFLKNGITE | 406 | P61764 | |
| RKNAIVVLIPKYGLE | 856 | Q9Y2L1 | |
| YRKVLGQLSARKLLQ | 41 | P01286 | |
| RLFILEKEGYVKILT | 241 | Q96QV1 | |
| RLGVLYDLDKQIKTI | 111 | Q9Y4F9 | |
| IIKIFKSDGLRGLYQ | 161 | P12235 | |
| LYRLQLSKAKGIVTI | 151 | Q08AH1 | |
| NKFVKTLKRGLYIAV | 431 | Q8N957 | |
| KKEYLQGLEARLQAV | 346 | Q99941 | |
| VFRRYLNKILIEAGK | 96 | Q96S66 | |
| LRGVVLKEYLTLKTF | 171 | P51788 | |
| KNRIAIYELLFKEGV | 6 | P46783 | |
| KIGIYQSLKRLFVER | 121 | O95258 | |
| LAKLLQERGISAKVY | 741 | O60296 | |
| IYVVDNGLRKILKVV | 321 | Q8IWX7 | |
| KDVIVGKIYFLLVRI | 186 | Q4G0F5 | |
| LKLNKDIVISVGIYN | 261 | P12956 | |
| VKEYIIQLSKGRLVL | 526 | Q03169 | |
| YKNLIILAGSELFKR | 41 | Q147U1 | |
| KVEGVYTNARKQLLI | 661 | Q70EL2 | |
| INNRLDLVKFYISKG | 91 | Q8IUH4 | |
| GTILKASVDYIRKLQ | 351 | O75030 | |
| GTILKASVDYIRKLQ | 386 | P19532 | |
| ETRLVLVNAIYFKGK | 156 | P50453 | |
| IQELYRSLVQKGLVK | 476 | A8MU46 | |
| VAILQERANKLVKYL | 441 | Q12816 | |
| LERSYLLKINGKVAE | 151 | P23921 | |
| EKIAKYGIRNSLLIA | 586 | P23921 | |
| VEIKLAKIGYLVFLR | 161 | C9JQI7 | |
| VGYKGTQLKALLILE | 101 | O75063 | |
| EYLEGRNLITKLQAK | 456 | O75044 | |
| YLRKTVLGKVIFQVI | 2251 | Q9H5I5 | |
| VLQSAIKLEYARLVK | 776 | Q9UHP3 | |
| QGIKDSLQKVILRRY | 101 | A6NP11 | |
| FKIINRKKDYIILGE | 1601 | Q9HCK1 | |
| KTYGRQILEVLKFLH | 266 | Q7Z7A4 | |
| FLNRYEKIVKKIRGL | 71 | O75116 | |
| RGAYLNALKIAKLLL | 1146 | O00507 | |
| GYLFILKNQVKEALL | 341 | Q8NDW8 | |
| VDGRKLLLYREQLVK | 686 | Q14997 | |
| LKRQGAQLYVEKLEL | 806 | Q9UPU5 | |
| IVGKIYFLLVRIKIQ | 191 | O75436 | |
| RLKSNYQLGELVKVE | 336 | Q9UIA9 | |
| ISQLIAGYIDIILKK | 391 | Q9Y4G6 | |
| AVARIKKGINYVLLK | 751 | Q01118 | |
| LYLRKTVLGKLAFQV | 2021 | Q92508 | |
| LGLKLQKFLVTYISL | 446 | Q13395 | |
| IQFETLGKKGKYIRL | 106 | Q7Z2W7 | |
| GNDQLLEILNKLIKY | 636 | Q15063 | |
| KLIKYIQIKFVRGST | 646 | Q15063 | |
| QEVKYLFTGLKLRLQ | 281 | P54578 | |
| NEKSGYQKLLELILL | 526 | Q69YN4 | |
| KTIIIKYFLNLINGA | 6 | P0C672 | |
| ELFLGLKIGELQKLY | 1081 | O60293 | |
| VYGALRCNILAIKIK | 181 | P51811 | |
| ALLVKYQGLVVKQLV | 726 | O94874 | |
| KIDYDVKRGVLLNAL | 361 | Q6ZT98 | |
| VLKFIGVLYKDKRLN | 396 | P53667 | |
| IGLQIKALIKKYIQR | 241 | P20592 | |
| KKQLSVAQLRGALVY | 561 | Q9Y3Q0 | |
| ILKSIEIAKNRGARY | 26 | Q6IA69 | |
| NEAAIKNVYLKVRGL | 1091 | P52179 |